ArticleOncoimmunology2026

Oncolytic virus OVV-03 enhances CAR-T cell therapy against glioblastoma via immune modulation and specific HER2 upregulation.

Yi Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.